A Phase 2 Study of Olaparib in combination with pembrolizumab in participants with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD)-positive advanced cancer
- Frentzas, Sophia (Primary Chief Investigator (PCI))
Project: Research